BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9596736)

  • 1. Indications of the protective role of natural killer cells in human cutaneous leishmaniasis in an area of endemicity.
    Maasho K; Sanchez F; Schurr E; Hailu A; Akuffo H
    Infect Immun; 1998 Jun; 66(6):2698-704. PubMed ID: 9596736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of amastigote reactive cells in human cutaneous leishmaniasis caused by Leishmania aethiopica.
    Maasho K; McMahon-Pratt D; Raita J; Raud M; Britton S; Soong L; Akuffo H
    Clin Exp Immunol; 2003 May; 132(2):316-22. PubMed ID: 12699423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction and abrogation of LACK reactive cells in the evolution of human leishmaniasis.
    Maasho K; Wolday D; Edjigu M; Söderström K; Britton S; Akuffo H
    Clin Exp Immunol; 2001 May; 124(2):255-61. PubMed ID: 11422202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural and acquired resistance to Leishmania: cellular activation by Leishmania aethiopica of mononuclear cells from unexposed individuals is through the stimulation of natural killer (NK) cells.
    Akuffo H; Maasho K; Howe R
    Clin Exp Immunol; 1993 Dec; 94(3):516-21. PubMed ID: 7902789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmanial amastigote antigen P-2 induces major histocompatibility complex class II-dependent natural killer-cell reactivity in cells from healthy donors.
    Nylén S; Maasho K; McMahon-Pratt D; Akuffo H
    Scand J Immunol; 2004 Mar; 59(3):294-304. PubMed ID: 15030581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and Functional Profiles of Antigen-Specific CD4
    Egui A; Ledesma D; Pérez-Antón E; Montoya A; Gómez I; Robledo SM; Infante JJ; Vélez ID; López MC; Thomas MC
    Front Cell Infect Microbiol; 2018; 8():393. PubMed ID: 30510917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of Leishmania braziliensis antigen-specific CD4+ T, CD8+ T, NK and CD3+CD56+NKT cells in the immunopathogenesis of cutaneous leishmaniasis patients: Cytotoxic, activation and exhaustion profiles.
    Cunha CF; Ferraz-Nogueira R; Costa VFA; Pimentel MIF; Chometon TQ; Lyra MR; Schubach AO; Da-Cruz AM; Bertho AL
    PLoS One; 2020; 15(3):e0229400. PubMed ID: 32203546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced activation of blood neutrophils and monocytes in patients with Ethiopian localized cutaneous leishmaniasis in response to Leishmania aethiopica Neutrophil activation in Ethiopian cutaneous leishmaniasis.
    Chanyalew M; Abebe M; Endale B; Girma S; Tasew G; Bobosha K; Zewide M; Howe R; van Zandbergen G; Ritter U; Gadisa E; Aseffa A; Laskay T
    Acta Trop; 2021 Aug; 220():105967. PubMed ID: 34029532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
    Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D
    Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell responses associated with resistance to Leishmania infection in individuals from endemic areas for Leishmania (Viannia) braziliensis.
    Bittar RC; Nogueira RS; Vieira-Gonçalves R; Pinho-Ribeiro V; Mattos MS; Oliveira-Neto MP; Coutinho SG; Da-Cruz AM
    Mem Inst Oswaldo Cruz; 2007 Aug; 102(5):625-30. PubMed ID: 17710308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD3
    Ferraz R; Cunha CF; Pimentel MIF; Lyra MR; Pereira-Da-Silva T; Schubach AO; Da-Cruz AM; Bertho AL
    Parasit Vectors; 2017 May; 10(1):219. PubMed ID: 28468680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of multi-epitope peptides containing HLA class-I and class-II-restricted epitopes derived from immunogenic Leishmania proteins, and evaluation of CD4+ and CD8+ T cell responses induced in cured cutaneous leishmaniasis subjects.
    Hamrouni S; Bras-Gonçalves R; Kidar A; Aoun K; Chamakh-Ayari R; Petitdidier E; Messaoudi Y; Pagniez J; Lemesre JL; Meddeb-Garnaoui A
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008093. PubMed ID: 32176691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NK cell activity differs between patients with localized and diffuse cutaneous leishmaniasis infected with Leishmania mexicana: a comparative study of TLRs and cytokines.
    Cañeda-Guzmán IC; Salaiza-Suazo N; Fernández-Figueroa EA; Carrada-Figueroa G; Aguirre-García M; Becker I
    PLoS One; 2014; 9(11):e112410. PubMed ID: 25397678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compartmentalized cytotoxic immune response leads to distinct pathogenic roles of natural killer and senescent CD8
    Covre LP; Devine OP; Garcia de Moura R; Vukmanovic-Stejic M; Dietze R; Ribeiro-Rodrigues R; Guedes HLM; Lubiana Zanotti R; Falqueto A; Akbar AN; Gomes DCO
    Immunology; 2020 Apr; 159(4):429-440. PubMed ID: 31925782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced production of pro-inflammatory cytokines and chemokines in Ethiopian cutaneous leishmaniasis upon exposure to Leishmania aethiopica.
    Chanyalew M; Abebe M; Endale B; Girma S; Tasew G; van Zandbergen G; Ritter U; Gadisa E; Aseffa A; Laskay T
    Cytokine; 2021 Sep; 145():155289. PubMed ID: 32951968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-γ Response Is Associated to Time Exposure Among Asymptomatic Immune Responders That Visited American Tegumentary Leishmaniasis Endemic Areas in Peru.
    Best I; Privat-Maldonado A; Cruz M; Zimic M; Bras-Gonçalves R; Lemesre JL; Arévalo J
    Front Cell Infect Microbiol; 2018; 8():289. PubMed ID: 30186774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice.
    Scharton TM; Scott P
    J Exp Med; 1993 Aug; 178(2):567-77. PubMed ID: 8101861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenetics of leishmanial and mycobacterial infections: the Belem Family Study.
    Blackwell JM; Black GF; Peacock CS; Miller EN; Sibthorpe D; Gnananandha D; Shaw JJ; Silveira F; Lins-Lainson Z; Ramos F; Collins A; Shaw MA
    Philos Trans R Soc Lond B Biol Sci; 1997 Sep; 352(1359):1331-45. PubMed ID: 9355125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania surface protein gp63 binds directly to human natural killer cells and inhibits proliferation.
    Lieke T; Nylén S; Eidsmo L; McMaster WR; Mohammadi AM; Khamesipour A; Berg L; Akuffo H
    Clin Exp Immunol; 2008 Aug; 153(2):221-30. PubMed ID: 18713141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Leishmania promastigote surface antigen-2 (PSA-2) is specifically recognised by Th1 cells in humans with naturally acquired immunity to L. major.
    Kemp M; Handman E; Kemp K; Ismail A; Mustafa MD; Kordofani AY; Bendtzen K; Kharazmi A; Theander TG
    FEMS Immunol Med Microbiol; 1998 Mar; 20(3):209-18. PubMed ID: 9566492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.